Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
514,715,255
-
Total 13F shares
-
324,190,091
-
Share change
-
+13,988,556
-
Total reported value
-
$1,581,950,465
-
Put/Call ratio
-
63%
-
Price per share
-
$4.88
-
Number of holders
-
321
-
Value change
-
+$66,787,219
-
Number of buys
-
174
-
Number of sells
-
127
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) as of Q3 2025
As of 30 Sep 2025,
RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) was held by
321 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
324,190,091 shares.
The largest 10 holders included
VANGUARD GROUP INC, ARK Investment Management LLC, BlackRock, Inc., BAILLIE GIFFORD & CO, STATE STREET CORP, SOFTBANK GROUP CORP., KINNEVIK AB (PUBL), Mubadala Investment Co PJSC, MIC Capital Management UK LLP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
321
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.